SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 224 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $435,606 | -8.3% | 15,800 | 0.0% | 0.06% | 0.0% |
| Q2 2023 | $474,948 | -17.0% | 15,800 | 0.0% | 0.06% | -14.1% |
| Q1 2023 | $572,434 | +11.4% | 15,800 | +9.7% | 0.07% | +10.9% |
| Q4 2022 | $513,648 | +38.1% | 14,400 | +30.9% | 0.06% | +25.5% |
| Q3 2022 | $372,000 | +17.0% | 11,000 | 0.0% | 0.05% | +27.5% |
| Q2 2022 | $318,000 | -10.7% | 11,000 | 0.0% | 0.04% | +8.1% |
| Q1 2022 | $356,000 | – | 11,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |